Citation
Chang, Y T., et al. "Absence of Molecular Defect in the Type II 3 Beta-hydroxysteroid Dehydrogenase (3 beta-HSD) Gene in Premature Pubarche Children and Hirsute Female Patients With Moderately Decreased Adrenal 3 beta-HSD Activity." Pediatric Research, vol. 37, no. 6, 1995, pp. 820-4.
Chang YT, Zhang L, Alkaddour HS, et al. Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity. Pediatr Res. 1995;37(6):820-4.
Chang, Y. T., Zhang, L., Alkaddour, H. S., Mason, J. I., Lin, K., Yang, X., Garibaldi, L. R., Bourdony, C. J., Dolan, L. M., & Donaldson, D. L. (1995). Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity. Pediatric Research, 37(6), 820-4.
Chang YT, et al. Absence of Molecular Defect in the Type II 3 Beta-hydroxysteroid Dehydrogenase (3 beta-HSD) Gene in Premature Pubarche Children and Hirsute Female Patients With Moderately Decreased Adrenal 3 beta-HSD Activity. Pediatr Res. 1995;37(6):820-4. PubMed PMID: 7651769.
TY - JOUR
T1 - Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity.
A1 - Chang,Y T,
AU - Zhang,L,
AU - Alkaddour,H S,
AU - Mason,J I,
AU - Lin,K,
AU - Yang,X,
AU - Garibaldi,L R,
AU - Bourdony,C J,
AU - Dolan,L M,
AU - Donaldson,D L,
PY - 1995/6/1/pubmed
PY - 1995/6/1/medline
PY - 1995/6/1/entrez
SP - 820
EP - 4
JF - Pediatric research
JO - Pediatr Res
VL - 37
IS - 6
N2 - To date the molecular basis and hormonal criteria for inherited mild late-onset 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency congenital adrenal hyperplasia (CAH) have not been defined. We have thus investigated the presence or absence of mutation in the type II 3 beta-HSD gene encoding adrenal/gonadal 3 beta-HSD in each of five premature pubarche children and hirsute female patients manifesting moderately decreased adrenal 3 beta-HSD activity. ACTH-stimulated hormonal levels in all patients compared with mean levels in pubertal stage-matched normal subjects were between 2.5 and 6.5 SD for 17-hydroxypregnenolone levels, and between 2.5 and 7 SD for dehydroepiandrosterone levels in all except one patient. 17-Hydroxypregnenolone to cortisol ratios were between 2.5 and 4.3 SD, and dehydroepiandrosterone to androstenedione ratios were between 3 and 8.6 SD. The type II 3 beta-HSD gene regions of a putative promoter, exons I, II, III, and IV, and exon-intron boundaries in all subjects were amplified by polymerase chain reaction and then sequenced. All patients had normal sequences of the type II 3 beta-HSD gene in both alleles. Three female patients heterozygotic for severe 3 beta-HSD deficiency CAH with one allele mutation of the gene demonstrated normal ACTH-stimulated hormone profiles. These data indicate that moderately decreased adrenal 3 beta-HSD activity resulting in modestly increased delta 5 precursor steroid levels and delta 5 to delta 4 steroid ratios in premature pubarche and hirsute patients is not caused by a mutation in the type II 3 beta-HSD gene.(ABSTRACT TRUNCATED AT 250 WORDS)
SN - 0031-3998
UR - https://www.unboundmedicine.com/medline/citation/7651769/Absence_of_molecular_defect_in_the_type_II_3_beta_hydroxysteroid_dehydrogenase__3_beta_HSD__gene_in_premature_pubarche_children_and_hirsute_female_patients_with_moderately_decreased_adrenal_3_beta_HSD_activity_
L2 - https://doi.org/10.1203/00006450-199506000-00024
DB - PRIME
DP - Unbound Medicine
ER -